Google clinical leader on health care’s AI ‘epistemic shift’

• by Julia Cipriano, MS, CMPP

• September 3, 2026

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• August 28, 2026

• 5 min

FDA expands essential thrombocythemia care

Phase 3 SURPASS ET data showed higher durable response rates with ropeginterferon alfa-2b-njft than with anagrelide.

• by Kathryn Wighton

• September 1, 2026

• 2 min

Risk models may improve lung cancer screening

Analysis found no single prediction model optimized screening eligibility, sensitivity, and efficiency across all racial and ethnic groups.

• by Olivia Anderson

• August 24, 2026

• 3 min